Matthew Moore
Geschäftsführer bei VENTYX BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.05.2024
Profil
Matthew Moore is currently the Chief Operating Officer at Ventyx Biosciences, Inc. He previously held the position of Vice President-Corporate Business Development at Allergan Ltd.
(Ireland) from 2015 to 2020.
Prior to that, he served as the Chief Business Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. from 2021 to 2024.
Mr. Moore completed his undergraduate degree at Trinity College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.05.2024 | 145 505 ( 0,13% ) | 1 Mio $ | 31.05.2024 | |
VENTYX BIOSCIENCES, INC.
-.--% | 16.05.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Matthew Moore
| Unternehmen | Position | Beginn |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Geschäftsführer | 16.05.2024 |
Ehemalige bekannte Positionen von Matthew Moore
| Unternehmen | Position | Ende |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2024 |
| ALLERGAN PLC | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Matthew Moore
| Trinity College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
